000			01977 a2200517 4500
005			20250515080323.0
264		0	_c20071206
008			200712s 0 0 eng d
022			_a0923-7534
024	7		_a10.1093/annonc/mdm170 _2doi
040			_aNLM _beng _cNLM
100	1		_aBeeram, M
245	0	0	_aAkt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2007
300			_a1323-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents, Hormonal _xpharmacology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAromatase Inhibitors _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm _xphysiology
650	0	4	_aEstradiol _xanalogs & derivatives
650	0	4	_aEverolimus
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aFulvestrant
650	0	4	_aHumans
650	0	4	_aLetrozole
650	0	4	_aNitriles _xpharmacology
650	0	4	_aProtein Kinases _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aSirolimus _xanalogs & derivatives
650	0	4	_aTOR Serine-Threonine Kinases
650	0	4	_aTriazoles _xpharmacology
700	1		_aTan, Q-T N
700	1		_aTekmal, R R
700	1		_aRussell, D
700	1		_aMiddleton, A
700	1		_aDeGraffenried, L A
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 18 _gno. 8 _gp. 1323-8
856	4	0	_uhttps://doi.org/10.1093/annonc/mdm170 _zAvailable from publisher's website
999			_c17225356 _d17225356